MedPath

Study on the cutoff value of exhaled nitric oxide (eNO) for prediction of asthma control levels

Not Applicable
Conditions
bronchial asthma
Registration Number
JPRN-UMIN000002263
Lead Sponsor
Showa University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with any of the following conditions are excluded: 1) Visited emergency room or were hospitalized due to exacerbation of asthma within 30 days prior to enrollment. 2) Treated with systemic corticosteroids within 30 days prior to enrollment. 3) Acquiring upper/lower respiratory tract infection within 30 days prior to enrollment. 4) Using inhaled corticosteroids solely or with long-acting beta2-agonists (LABAs) at a dosage that exceeds the approved one. 5) Complicating pulmonary diseases as follows: COPD, bronchiectasis, primary pulmonary cancer, connective tissue disease, pulmonary hypertension, and/or cystic disease of the lungs 6) Current smokers

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath